These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 17136985)

  • 1. Prevalence and risk factors for chronic obstructive pulmonary disease according to symptoms and spirometry.
    Menezes A; Macedo SC; Gigante DP; da Costa JD; Olinto MT; Fiss E; Chatkin M; Hallal PC; Victora CG
    COPD; 2004; 1(2):173-9. PubMed ID: 17136985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estimating prevalence of chronic obstructive pulmonary disease in the Southern Cone of Latin America: how different spirometric criteria may affect disease burden and health policies.
    Sobrino E; Irazola VE; Gutierrez L; Chen CS; Lanas F; Calandrelli M; Ponzo J; Mores N; Serón P; Lee A; He J; Rubinstein AL
    BMC Pulm Med; 2017 Dec; 17(1):187. PubMed ID: 29228947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seven-year cumulative incidence of COPD in an age-stratified general population sample.
    Lindberg A; Eriksson B; Larsson LG; Rönmark E; Sandström T; Lundbäck B
    Chest; 2006 Apr; 129(4):879-85. PubMed ID: 16608933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spirometry, questionnaire and electronic medical record based COPD in a population survey: Comparing prevalence, level of agreement and associations with potential risk factors.
    Borlée F; Yzermans CJ; Krop E; Aalders B; Rooijackers J; Zock JP; van Dijk CE; Maassen CB; Schellevis F; Heederik D; Smit LA
    PLoS One; 2017; 12(3):e0171494. PubMed ID: 28273094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic obstructive pulmonary disease with mild airflow limitation: current knowledge and proposal for future research - a consensus document from six scientific societies.
    Rossi A; Butorac-Petanjek B; Chilosi M; Cosío BG; Flezar M; Koulouris N; Marin J; Miculinic N; Polese G; Samaržija M; Skrgat S; Vassilakopoulos T; Vukić-Dugac A; Zakynthinos S; Miravitlles M
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2593-2610. PubMed ID: 28919728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of chronic obstructive pulmonary disease according to BTS, ERS, GOLD and ATS criteria in relation to doctor's diagnosis, symptoms, age, gender, and smoking habits.
    Lindberg A; Jonsson AC; Rönmark E; Lundgren R; Larsson LG; Lundbäck B
    Respiration; 2005; 72(5):471-9. PubMed ID: 16210885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.
    Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COPD in chronic heart failure: less common than previously thought?
    Minasian AG; van den Elshout FJ; Dekhuijzen PN; Vos PJ; Willems FF; van den Bergh PJ; Heijdra YF
    Heart Lung; 2013; 42(5):365-71. PubMed ID: 23998385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voluntary lung function screening to reveal new COPD cases in southern Italy.
    Capozzolo A; Castellana G; Dragonieri S; Carratù P; Liotino V; Vulpi MR; Marra L; Resta E; Intiglietta P; Resta O
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2035-2042. PubMed ID: 28744118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of chronic obstructive pulmonary disease in Riyadh, Saudi Arabia: a BOLD study.
    Al Ghobain M; Alhamad EH; Alorainy HS; Al Kassimi F; Lababidi H; Al-Hajjaj MS
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1252-7. PubMed ID: 26459542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COPD prevalence in a north-eastern Italian general population.
    Guerriero M; Caminati M; Viegi G; Senna G; Cesana G; Pomari C
    Respir Med; 2015 Aug; 109(8):1040-7. PubMed ID: 26052037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COPD 'diagnosis' based on spirometric reference equations.
    Olofson J; Bake B; Tengelin MN; Houltz B
    Clin Respir J; 2008 Oct; 2(4):214-9. PubMed ID: 20298337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of chronic obstructive pulmonary disease and associated factors: the PLATINO Study in São Paulo, Brazil.
    Menezes AM; Jardim JR; Pérez-Padilla R; Camelier A; Rosa F; Nascimento O; Hallal PC
    Cad Saude Publica; 2005; 21(5):1565-73. PubMed ID: 16158163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands.
    Vanfleteren LE; Franssen FM; Wesseling G; Wouters EF
    Respir Med; 2012 Jun; 106(6):871-4. PubMed ID: 22349067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of using the new GOLD classification on the distribution of COPD severity in clinical practice.
    Hernández M; García G; Falco J; García AR; Martín V; Ibarrola M; Quadrelli S
    Int J Chron Obstruct Pulmon Dis; 2018; 13():351-356. PubMed ID: 29403272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fixed ratio or lower limit of normal for the FEV
    Wollmer P; Frantz S; Engström G; Dencker M; Löfdahl CG; Nihlén U
    Clin Physiol Funct Imaging; 2017 May; 37(3):263-269. PubMed ID: 26443700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stratification of patients with COPD according to the 2011 GOLD report.
    Grzelewska-Rzymowska I; Patora-Mikołajczyk J; Górski P
    Pneumonol Alergol Pol; 2014; 82(5):415-21. PubMed ID: 25133809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey.
    Zhong N; Wang C; Yao W; Chen P; Kang J; Huang S; Chen B; Wang C; Ni D; Zhou Y; Liu S; Wang X; Wang D; Lu J; Zheng J; Ran P
    Am J Respir Crit Care Med; 2007 Oct; 176(8):753-60. PubMed ID: 17575095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.
    Danielsson P; Ólafsdóttir IS; Benediktsdóttir B; Gíslason T; Janson C
    Clin Respir J; 2012 Apr; 6(2):120-7. PubMed ID: 21651748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gender and chronic obstructive pulmonary disease in high-risk smokers.
    de Torres JP; Campo A; Casanova C; Aguirre-Jaime A; Zulueta J
    Respiration; 2006; 73(3):306-10. PubMed ID: 16330871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.